$8.08
0.466.04%
At close: -
$8.30
0.222.72%
After Hours: Feb 21, 5:42 PM EDT
Comments
Loading...
Abivax (NASDAQ:ABVX) Stock Quotes, Forecast and News Summary
Abivax Stock (NASDAQ: ABVX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Abivax (ABVX) stock?
You can purchase shares of Abivax (NASDAQ:ABVX) through any online brokerage.
Who are Abivax (ABVX) competitors?
Other companies in Abivax’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Humacyte (NASDAQ:HUMA), KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC) and Upstream Bio (NASDAQ:UPB).
What is the forecast, or price target, for Abivax (ABVX) stock?
Abivax has a consensus price target of $35.63.
What is the current price for Abivax (ABVX)?
The stock price for Abivax (NASDAQ: ABVX) is $8.3 last updated February 21, 2025 at 5:42 PM EST.
Does Abivax (ABVX) pay a dividend?
There are no upcoming dividends for Abivax.
When is Abivax (NASDAQ:ABVX) reporting earnings?
Abivax’s FY earnings are confirmed for Monday, March 24, 2025.
Is Abivax (ABVX) going to split?
There is no upcoming split for Abivax.
What sector and industry does Abivax (ABVX) operate in?
Abivax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.